NEKTAR THERAPEUTICS (NKTR)       2.9  -0.01 (-0.34%)

2.9  -0.01 (-0.34%)

US6402681083 - Common Stock - After market: 2.9 0 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.31 -0.46 0.1532.39% Q2 2022 -0.85 -0.95 0.1010.99% Q1 2022 -0.49 -0.69 0.2029.07% Q4 2021 -0.79 -0.83 0.044.31% Q3 2021 -0.70 -0.81 0.1114.04% Q2 2021 -0.69 -0.75 0.067.44% Q1 2021 -0.67 -0.74 0.079.02% Q4 2020 -0.65 -0.69 0.046.27%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -2.22 -2.85 22.24%Q4 2022 -0.46 -0.79 41.99%FY 2023 -1.09 -2.22 50.91%Q1 2023 -0.23 -0.49 52.54%Q2 2023 -0.24 -0.85 71.20%Q3 2023 -0.24 -0.31 23.01%Q4 2023 -0.20 -0.46 57.16%FY 2024 -1.03 -1.09 5.71%Q1 2024 -0.21 -0.23 7.89%Q2 2024 -0.21 -0.24 12.50%Q3 2024 -0.21 -0.24 10.26%Q4 2024 -0.20 -0.20 -3.90%FY 2025 -1.29 -1.03 -25.79%FY 2026 -1.66 -1.29 -28.31%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 23.625M 23.061M 564K2.45% Q2 2022 21.585M 23.118M -1.533M-6.63% Q1 2022 24.822M 24.865M -43K-0.17% Q4 2021 25.009M 25.84M -831K-3.22% Q3 2021 24.921M 28.425M -3.504M-12.33% Q2 2021 28.33M 26.5M 1.83M6.91% Q1 2021 23.6M 27.442M -3.842M-14.00% Q4 2020 23.5M 30.615M -7.115M-23.24%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 92.629M 101.907M -9.10%Q4 2022 22.532M 25.009M -9.90%FY 2023 92.788M 92.629M 0.17%Q1 2023 23.042M 24.822M -7.17%Q2 2023 23.042M 21.585M 6.75%Q3 2023 23.042M 23.625M -2.47%Q4 2023 26.52M 22.532M 17.70%FY 2024 102.4M 92.788M 10.36%Q1 2024 27.54M 23.042M 19.52%Q2 2024 27.54M 23.042M 19.52%Q3 2024 27.54M 23.042M 19.52%Q4 2024 27.54M 26.52M 3.85%FY 2025 103.04M 102.4M 0.63%FY 2026 104.13M 103.04M 1.06%